Genentech opens up eye patients’ world with Vabysmo

Genentech unveiled Open Up Your World with Vabysmo, its latest direct-to-consumer (DTC) campaign, Thursday morning.

The biotech’s effort seeks to empower patients with eye disease, specifically wet age-related macular degeneration (AMD) and diabetic macular edema (DME), to explore treatment options that can preserve their vision.